PubRank

E Hamelmann

Author PubWeight™ 53.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 1997 2.36
2 Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest 1997 2.10
3 Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J Clin Invest 1996 1.86
4 Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients. Clin Exp Allergy 2005 1.76
5 Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007 1.54
6 Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol 1996 1.52
7 Mast cell tumor necrosis factor alpha production is regulated by MEK kinases. Proc Natl Acad Sci U S A 1997 1.28
8 Specific oral tolerance induction with food in children: transient or persistent effect on food allergy? Allergy 2005 1.16
9 IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J Immunol 1999 1.12
10 CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J Immunol 1999 1.10
11 Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. J Immunol 1999 1.09
12 EAACI position statement on asthma exacerbations and severe asthma. Allergy 2013 1.07
13 Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma. Clin Exp Allergy 2008 1.03
14 Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1999 1.02
15 CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness. Am J Respir Crit Care Med 2000 0.99
16 Antigen-specific immunoglobulin-A prevents increased airway responsiveness and lung eosinophilia after airway challenge in sensitized mice. Am J Respir Crit Care Med 1998 0.99
17 Neurokinin-1 receptor activation induces reactive oxygen species and epithelial damage in allergic airway inflammation. Clin Exp Allergy 2007 0.97
18 Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice. Clin Exp Allergy 2004 0.95
19 Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice. J Allergy Clin Immunol 1998 0.92
20 Longitudinal trends of total and allergen-specific IgE throughout childhood. Allergy 2009 0.91
21 Barometric whole body plethysmography in mice. J Appl Physiol (1985) 2005 0.90
22 First autologous cell therapy of cerebral palsy caused by hypoxic-ischemic brain damage in a child after cardiac arrest-individual treatment with cord blood. Case Rep Transplant 2013 0.88
23 Gastrointestinal nematode infection interferes with experimental allergic airway inflammation but not atopic dermatitis. Clin Exp Allergy 2009 0.87
24 BCG priming of dendritic cells enhances T regulatory and Th1 function and suppresses allergen-induced Th2 function in vitro and in vivo. Int Arch Allergy Immunol 2009 0.87
25 Dynamic evolution of serum immunoglobulin E to airborne allergens throughout childhood: results from the Multi-Centre Allergy Study birth cohort. Clin Exp Allergy 2009 0.86
26 Lipocalin2 protects against airway inflammation and hyperresponsiveness in a murine model of allergic airway disease. Clin Exp Allergy 2010 0.86
27 Modulation of antigen-induced B and T cell responses by antigen-specific IgE antibodies. J Immunol 1997 0.86
28 Master switches of T-cell activation and differentiation. Eur Respir J 2007 0.85
29 CD23 deficient mice develop allergic airway hyperresponsiveness following sensitization with ovalbumin. Am J Respir Crit Care Med 1997 0.85
30 Allergic lung inflammation induces pulmonary vascular hyperresponsiveness. Eur Respir J 2006 0.84
31 Specific IgE serum concentration is associated with symptom severity in children with seasonal allergic rhinitis. Allergy 2008 0.84
32 The role of lipocalins in airway disease. Clin Exp Allergy 2013 0.84
33 The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. Allergy 2004 0.84
34 Ultrasound and colour Doppler in infantile subglottic haemangioma. Pediatr Radiol 2011 0.83
35 Endotoxins and allergy: lessons from the murine model. Pathobiology 2003 0.82
36 Therapeutic potential of larval excretory/secretory proteins of the pig whipworm Trichuris suis in allergic disease. Allergy 2014 0.82
37 Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease. Clin Exp Allergy 2005 0.81
38 Transcriptional up-regulation of histamine receptor-1 in epithelial, mucus and inflammatory cells in perennial allergic rhinitis. Clin Exp Allergy 2005 0.81
39 Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. Int Arch Allergy Immunol 2001 0.81
40 T-cell co-stimulatory molecules: their role in allergic immune reactions. Eur Respir J 2007 0.80
41 Glutathione peroxidase-2 protects from allergen-induced airway inflammation in mice. Eur Respir J 2009 0.79
42 Questionnaire to preselect patients with a high probability of primary ciliary dyskinesia. Klin Padiatr 2010 0.79
43 Differential regulation of CD40-mediated human B cell responses by antibodies directed against different CD40 epitopes. Cell Immunol 2000 0.79
44 Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering. Respir Med 2009 0.79
45 Gene expression profiling as novel tool in experimental asthma research. Exp Toxicol Pathol 2006 0.78
46 T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease. Eur Respir J 2007 0.78
47 Interleukin-5: a novel target for asthma therapy. Expert Opin Biol Ther 2001 0.78
48 Oral administration of desloratadine prior to sensitization prevents allergen-induced airway inflammation and hyper-reactivity in mice. Clin Exp Allergy 2004 0.78
49 Prenatal allergen exposures prevent allergen-induced sensitization and airway inflammation in young mice. Allergy 2012 0.78
50 Common vaccine antigens inhibit allergen-induced sensitization and airway hyperresponsiveness in a murine model. Allergy 2006 0.77
51 Intranasal delivery of whole influenza vaccine prevents subsequent allergen-induced sensitization and airway hyper-reactivity in mice. Clin Exp Allergy 2007 0.77
52 Inhaled corticosteroid improves bronchial reactivity and decreases symptoms in patients with mitral stenosis. Chest 1998 0.77
53 Immune responses to allergens early in life: when and why do allergies arise? Clin Exp Allergy 2002 0.76
54 [The German severe asthma registry]. Pneumologie 2012 0.75
55 Pretreatment with allergen prevents immediate hypersensitivity and airway hyperresponsiveness. Am J Respir Crit Care Med 1996 0.75
56 Transcription factors: new targets for antiallergic therapy. Pathobiology 2003 0.75
57 Targeting transcription: a new concept of anti-inflammatory therapy of airway diseases. Curr Drug Targets 2006 0.75